Official SEC submissions

Neuphoria Therapeutics SEC Filings

Direct answer

Neuphoria Therapeutics's latest SEC filing is DEFA14A.

It was filed on September 18, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

DEFA14A

Proxy statement

Filed: 2026-09-18

DEFA14A

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-09-18

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-09-18

Report date: 2026-11-02

DEF 14A

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-09-18

Report date: 2026-06-30

10-K

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-07-24

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-24

Report date: 2026-07-20

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-26

Report date: 2026-05-21

CURRENT REPORT

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-15

Report date: 2026-03-31

10-Q

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-02-17

Report date: 2025-12-31

10-Q

Open SEC document View filing index

4

Insider transaction

Filed: 2026-01-21

Report date: 2026-01-20

Open SEC document View filing index

4

Insider transaction

Filed: 2026-01-21

Report date: 2026-01-20

Open SEC document View filing index

4

Insider transaction

Filed: 2026-01-21

Report date: 2026-01-20

Open SEC document View filing index

4

Insider transaction

Filed: 2026-01-21

Report date: 2026-01-20

Open SEC document View filing index

8-K

Current report

Filed: 2026-01-08

Report date: 2025-12-31

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2025-12-18

Report date: 2025-12-18

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2025-12-17

Report date: 2025-12-12

CURRENT REPORT

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-12-08

DEFINITIVE ADDITIONAL MATERIALS

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-12-04

DEFINITIVE ADDITIONAL MATERIALS

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-12-01

DEFINITIVE ADDITIONAL MATERIALS

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-11-25

DEFINITIVE ADDITIONAL MATERIALS

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-11-24

DEFINITIVE ADDITIONAL MATERIALS

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-14

Report date: 2025-09-30

10-Q

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-11-12

SOLICITING MATERIAL UNDER 240. RULE 14A-12

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2025-10-30

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2025-10-30

Report date: 2025-12-09

DEF 14A

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-27

Report date: 2025-10-27

CURRENT REPORT

Open SEC document View filing index

4

Insider transaction

Filed: 2025-10-23

Report date: 2025-10-21

Open SEC document View filing index

8-K

Current report

Filed: 2025-10-20

Report date: 2025-10-20

CURRENT REPORT

Open SEC document View filing index

10-K

Periodic report

Filed: 2025-09-29

Report date: 2025-06-30

10-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-09-16

Report date: 2025-09-10

CURRENT REPORT

Open SEC document View filing index

4

Insider transaction

Filed: 2025-09-02

Report date: 2025-08-27

Open SEC document View filing index

8-K

Current report

Filed: 2025-07-18

Report date: 2025-07-18

CURRENT REPORT

Open SEC document View filing index

8-K

Current report

Filed: 2025-05-20

Report date: 2025-05-20

CURRENT REPORT

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-05-20

Report date: 2025-03-31

10-Q

Open SEC document View filing index

4/A

Insider transaction

Filed: 2025-05-19

Report date: 2025-04-16

Open SEC document View filing index

4

Insider transaction

Filed: 2025-04-18

Report date: 2025-04-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

4

Insider transaction

Filed: 2025-04-18

Report date: 2025-04-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

4

Insider transaction

Filed: 2025-04-18

Report date: 2025-04-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

4

Insider transaction

Filed: 2025-04-18

Report date: 2025-04-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

4

Insider transaction

Filed: 2025-04-18

Report date: 2025-04-16

OWNERSHIP DOCUMENT

Open SEC document View filing index

Verified data

Recent filing categories: 4
Recent filings: 40
SEC CIK: 0001191070
Latest filing date: September 18, 2026

Explore related company data

View the Neuphoria Therapeutics company profile View Neuphoria Therapeutics annual financials